Sino Biological launches lab validation for AI-designed proteins, citing three-day binding data
The 4RISE service combines protein production, binding measurements and software access to results. Its fastest turnaround concerns binding data, not the full set of biological tests.
Launched on November 13, 2026, Sino Biological’s 4RISE combines protein production with laboratory binding tests for teams developing AI-designed proteins. The company says applicable workflows can return binding data in as little as three days, but that is not a universal turnaround: XPressMAX synthesis alone is reported at three hours. Four service tracks cover hit finding through quantitative lead characterization, with results available via API for integration into research software.
01
Sino Biological reports XPressMAX expression success above 99% in established workflows, not for every newly designed AI candidate.
02
Binding measurements use Carterra and Biacore surface plasmon resonance instruments and Octet bio-layer interferometry.
03
The service description lists more than 11,000 ready-to-use target proteins and real-time access to structured binding data through an API.
AI-designed proteins need physical tests to show whether they bind their intended targets. Sino Biological launched 4RISE on November 13, 2026, to provide that laboratory validation. The company says its service can return structured binding data in as little as three days, with results accessible through a software interface.
First, make the candidate protein
The workflow begins with protein expression: producing the protein that researchers want to evaluate. Sino Biological uses its XPressMAX cell-free protein synthesis platform for this step. It says the platform can produce recombinant proteins in three hours, giving researchers physical candidates for experimental testing rather than only computational predictions.
The company reports expression success rates above 99% in established workflows. That qualification matters: the figure describes those workflows, rather than a stated success rate for every newly designed AI candidate. Supported formats include miniproteins, several antibody formats, enzymes and cytokines, allowing the production step to serve different types of protein-design projects.
Next comes measurement. 4RISE uses Carterra and Biacore surface plasmon resonance instruments, along with Octet bio-layer interferometry, to screen binding and characterize its strength and kinetics. These methods supply experimental measurements of candidate–target interactions. Combined with cell-free production, this is the sequence-to-binding-data workflow behind the company's three-day claim.
Four routes through screening
4RISE is not presented as one fixed test for every molecule. The launch describes four service tracks, selected around the candidate format and the validation objective. They range from finding initial binding-positive candidates to comparing purified proteins and obtaining more detailed measurements for lead selection.
Rapid Hit Discovery screens miniproteins and VHH antibody fragments in crude supernatant, looking for candidates that bind the target. This route focuses on identifying positive hits before the purified-candidate comparison offered in another track.
Comparative Binder Screening evaluates purified candidates under standardized conditions. Its stated purpose is candidate prioritization: giving researchers a consistent basis for comparing the proteins they are considering for further work.
Affinity & Kinetic Characterization provides quantitative binding measurements for lead selection. It moves beyond identifying a binding-positive candidate to measuring binding properties that researchers can use when choosing which leads to advance.
Specialized Binder Expression & Validation pairs tailored mammalian expression with binding analysis for diverse binder formats. It provides a production-and-testing route alongside the cell-free workflows highlighted in the service's fastest turnaround claims.
Binding results feed back into research
The software connection is part of the service, not just the delivery of a laboratory report. Sino Biological says structured target-binding data are accessible in real time through an application programming interface, or API. That lets research software retrieve the results for downstream analysis and integration into subsequent research and optimization workflows.
The company's accompanying service description also lists more than 11,000 ready-to-use target proteins. It brings together cell-free and mammalian expression, antibody production, binding characterization and functional validation. The offering therefore covers both making candidates and evaluating them, rather than supplying binding measurements as an isolated step.
Binding is only one layer of that evaluation. Sino Biological also offers more than 20 developability assays to assess candidate quality, more than 1,000 protein bioactivity assays and more than 10 cell-based functional assays. The three-day headline concerns binding data; the broader service extends to how candidates behave biologically.
Sources
biospace.comSino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery
news-medical.netSino Biological advances AI-designed molecule validation with 4RISE™
Reader comments
Newest comments first. Replies stay oldest first.